JPVAS prospective cohort study for vasculitides

JPVAS prospective cohort study for vasculitides [RADDAR-J [22] ] - JPVAS prospective cohort study for vasculitides

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039295

Enrollment

3000

Registered

2020-01-29

Start date

2020-09-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), Takayasu arteritis (TAK), giant cell arteritis (GCA)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects who were diagnosed as having either MPA, GPA, EGPA, TAC, or GCA according to the diagnostic criteria of Ministry of Health, Labour and Welfare 2. Subjects who provided written informed consent

Exclusion criteria

Exclusion criteria: Subjects who were judged ineligible by investigators

Design outcomes

Primary

Measure	Time frame
BVAS remission rate at one year, time to recurrence, mortality rate at five years, serious infection	—

Countries

Japan

Contacts

Public ContactTomoaki Higuchi

Tokyo Women's Medical University Hospital Department of Rheumatology

higuchi.tomoaki@twmu.ac.jp03-5269-1725

Outcome results